Changes related to "Category:Oculoplastics/Orbit"

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options

Legend:

N: This edit created a new page (also see list of new pages)
m: This is a minor edit
b: This edit was performed by a bot
(±123): The page size changed by this number of bytes

Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits
Show new changes starting from 15:47, February 24, 2021

February 24, 2021

m 11:46

Neuroblastoma‎ (diff | hist) . . (+14)‎ . . Tony.Ching.AAO (Talk | contribs) (→‎minor formatting)

February 23, 2021

	19:09	(Move log)‎ . . [Tony.Ching.AAO‎ (4×)]
		19:09 . . Tony.Ching.AAO (Talk \| contribs) moved page Canalicular obstruction to Canalicular Obstruction ‎(‎title standardization)
		18:52 . . Tony.Ching.AAO (Talk \| contribs) moved page Canalicular laceration (trauma) to Canalicular Laceration (Trauma) ‎(‎title standardization)
		18:17 . . Tony.Ching.AAO (Talk \| contribs) moved page Bloody tears to Bloody Tears ‎(‎title standardization)
		18:15 . . Tony.Ching.AAO (Talk \| contribs) moved page Blepharophimosis syndrome to Blepharophimosis Syndrome ‎(‎title standardization)

	01:03	Teprotumumab‎‎ (3 changes \| history) . . (+136)‎ . . [Lalita.Gupta‎ (3×)]
	m	01:03 (cur \| prev) . . (+2)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Overview) (Tag: VisualEditor)
	m	00:54 (cur \| prev) . . (+127)‎ . . Lalita.Gupta (Talk \| contribs)
		00:15 (cur \| prev) . . (+7)‎ . . Lalita.Gupta (Talk \| contribs)

February 22, 2021

	22:08	Teprotumumab‎‎ (16 changes \| history) . . (+920)‎ . . [Lalita.Gupta‎ (16×)]
		22:08 (cur \| prev) . . (+24)‎ . . Lalita.Gupta (Talk \| contribs)
		20:54 (cur \| prev) . . (+2)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Mechanism of Action)
		20:53 (cur \| prev) . . (-16)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Mechanism of Action) (Tag: VisualEditor)
	m	20:50 (cur \| prev) . . (-23)‎ . . Lalita.Gupta (Talk \| contribs) (Tag: VisualEditor)
		20:45 (cur \| prev) . . (-8)‎ . . Lalita.Gupta (Talk \| contribs)
		20:39 (cur \| prev) . . (+10)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Overview) (Tag: VisualEditor)
	m	20:38 (cur \| prev) . . (-10)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Overview) (Tag: VisualEditor)
	m	20:36 (cur \| prev) . . (+2)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Overview) (Tag: VisualEditor)
	m	20:35 (cur \| prev) . . (+1)‎ . . Lalita.Gupta (Talk \| contribs) (mino) (Tag: VisualEditor)
		20:34 (cur \| prev) . . (-19)‎ . . Lalita.Gupta (Talk \| contribs)
		20:31 (cur \| prev) . . (+7)‎ . . Lalita.Gupta (Talk \| contribs) (picture) (Tag: VisualEditor)
		20:23 (cur \| prev) . . (+37)‎ . . Lalita.Gupta (Talk \| contribs) (Tag: VisualEditor)
		20:16 (cur \| prev) . . (+51)‎ . . Lalita.Gupta (Talk \| contribs)
		20:12 (cur \| prev) . . (+221)‎ . . Lalita.Gupta (Talk \| contribs) (picture) (Tag: VisualEditor)
		20:04 (cur \| prev) . . (+218)‎ . . Lalita.Gupta (Talk \| contribs)
		19:59 (cur \| prev) . . (+423)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Overview) (Tag: VisualEditor)

February 21, 2021

	N 20:05	Teprotumumab‎‎ (26 changes \| history) . . (+19,870)‎ . . [Lalita.Gupta‎ (26×)]
		20:05 (cur \| prev) . . (-4)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Pharmacokinetics) (Tag: VisualEditor)
		19:55 (cur \| prev) . . (+9)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety)
		19:34 (cur \| prev) . . (+9)‎ . . Lalita.Gupta (Talk \| contribs)
		19:09 (cur \| prev) . . (+6)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety) (Tag: VisualEditor)
		19:08 (cur \| prev) . . (+13)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety) (Tag: VisualEditor)
		19:07 (cur \| prev) . . (+7)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety)
		19:04 (cur \| prev) . . (+46)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety)
		18:54 (cur \| prev) . . (+14)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety: table) (Tag: VisualEditor)
		18:52 (cur \| prev) . . (+760)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety) (Tag: VisualEditor)
		18:46 (cur \| prev) . . (+8)‎ . . Lalita.Gupta (Talk \| contribs)
		18:45 (cur \| prev) . . (-8)‎ . . Lalita.Gupta (Talk \| contribs)
		18:43 (cur \| prev) . . (-11)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Mechanism of Action)
		18:41 (cur \| prev) . . (+42)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Overview) (Tag: VisualEditor)
		18:38 (cur \| prev) . . (+102)‎ . . Lalita.Gupta (Talk \| contribs)
		18:26 (cur \| prev) . . (+23)‎ . . Lalita.Gupta (Talk \| contribs)
		18:22 (cur \| prev) . . (+328)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety)
		18:20 (cur \| prev) . . (+1)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Indications)
		18:19 (cur \| prev) . . (-3)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Indications)
		18:19 (cur \| prev) . . (+446)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Indications)
		18:16 (cur \| prev) . . (+528)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Clinical trials)
		18:13 (cur \| prev) . . (+18)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Dosing and Administration)
		18:12 (cur \| prev) . . (-12)‎ . . Lalita.Gupta (Talk \| contribs) (→‎References)
		18:11 (cur \| prev) . . (+240)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Pharmacokinetics)
		18:09 (cur \| prev) . . (+1,911)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Mechanism of Action)
		18:02 (cur \| prev) . . (+3,512)‎ . . Lalita.Gupta (Talk \| contribs) (Tag: VisualEditor: Switched)
	N	17:33 (cur \| prev) . . (+11,885)‎ . . Lalita.Gupta (Talk \| contribs) (Created page with "{{Article \|Authors=Lalita Gupta,Mark Prendes,Raymond Douglas \|Category=Oculoplastics/Orbit \|Date reviewed=February 21, 2021 \|Meta description=Teprotumumab is a fully human mon...")

Namespace:	Invert selection Associated namespace
Tag filter:
Page name:	Show changes to pages linked to the given page instead

	19:09	(Move log)‎ . . [Tony.Ching.AAO‎ (4×)]
		19:09 . . Tony.Ching.AAO (Talk \| contribs) moved page Canalicular obstruction to Canalicular Obstruction ‎(‎title standardization)
		18:52 . . Tony.Ching.AAO (Talk \| contribs) moved page Canalicular laceration (trauma) to Canalicular Laceration (Trauma) ‎(‎title standardization)
		18:17 . . Tony.Ching.AAO (Talk \| contribs) moved page Bloody tears to Bloody Tears ‎(‎title standardization)
		18:15 . . Tony.Ching.AAO (Talk \| contribs) moved page Blepharophimosis syndrome to Blepharophimosis Syndrome ‎(‎title standardization)

	01:03	Teprotumumab‎‎ (3 changes \| history) . . (+136)‎ . . [Lalita.Gupta‎ (3×)]
	m	01:03 (cur \| prev) . . (+2)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Overview) (Tag: VisualEditor)
	m	00:54 (cur \| prev) . . (+127)‎ . . Lalita.Gupta (Talk \| contribs)
		00:15 (cur \| prev) . . (+7)‎ . . Lalita.Gupta (Talk \| contribs)

	22:08	Teprotumumab‎‎ (16 changes \| history) . . (+920)‎ . . [Lalita.Gupta‎ (16×)]
		22:08 (cur \| prev) . . (+24)‎ . . Lalita.Gupta (Talk \| contribs)
		20:54 (cur \| prev) . . (+2)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Mechanism of Action)
		20:53 (cur \| prev) . . (-16)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Mechanism of Action) (Tag: VisualEditor)
	m	20:50 (cur \| prev) . . (-23)‎ . . Lalita.Gupta (Talk \| contribs) (Tag: VisualEditor)
		20:45 (cur \| prev) . . (-8)‎ . . Lalita.Gupta (Talk \| contribs)
		20:39 (cur \| prev) . . (+10)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Overview) (Tag: VisualEditor)
	m	20:38 (cur \| prev) . . (-10)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Overview) (Tag: VisualEditor)
	m	20:36 (cur \| prev) . . (+2)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Overview) (Tag: VisualEditor)
	m	20:35 (cur \| prev) . . (+1)‎ . . Lalita.Gupta (Talk \| contribs) (mino) (Tag: VisualEditor)
		20:34 (cur \| prev) . . (-19)‎ . . Lalita.Gupta (Talk \| contribs)
		20:31 (cur \| prev) . . (+7)‎ . . Lalita.Gupta (Talk \| contribs) (picture) (Tag: VisualEditor)
		20:23 (cur \| prev) . . (+37)‎ . . Lalita.Gupta (Talk \| contribs) (Tag: VisualEditor)
		20:16 (cur \| prev) . . (+51)‎ . . Lalita.Gupta (Talk \| contribs)
		20:12 (cur \| prev) . . (+221)‎ . . Lalita.Gupta (Talk \| contribs) (picture) (Tag: VisualEditor)
		20:04 (cur \| prev) . . (+218)‎ . . Lalita.Gupta (Talk \| contribs)
		19:59 (cur \| prev) . . (+423)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Overview) (Tag: VisualEditor)

	N 20:05	Teprotumumab‎‎ (26 changes \| history) . . (+19,870)‎ . . [Lalita.Gupta‎ (26×)]
		20:05 (cur \| prev) . . (-4)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Pharmacokinetics) (Tag: VisualEditor)
		19:55 (cur \| prev) . . (+9)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety)
		19:34 (cur \| prev) . . (+9)‎ . . Lalita.Gupta (Talk \| contribs)
		19:09 (cur \| prev) . . (+6)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety) (Tag: VisualEditor)
		19:08 (cur \| prev) . . (+13)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety) (Tag: VisualEditor)
		19:07 (cur \| prev) . . (+7)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety)
		19:04 (cur \| prev) . . (+46)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety)
		18:54 (cur \| prev) . . (+14)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety: table) (Tag: VisualEditor)
		18:52 (cur \| prev) . . (+760)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety) (Tag: VisualEditor)
		18:46 (cur \| prev) . . (+8)‎ . . Lalita.Gupta (Talk \| contribs)
		18:45 (cur \| prev) . . (-8)‎ . . Lalita.Gupta (Talk \| contribs)
		18:43 (cur \| prev) . . (-11)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Mechanism of Action)
		18:41 (cur \| prev) . . (+42)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Overview) (Tag: VisualEditor)
		18:38 (cur \| prev) . . (+102)‎ . . Lalita.Gupta (Talk \| contribs)
		18:26 (cur \| prev) . . (+23)‎ . . Lalita.Gupta (Talk \| contribs)
		18:22 (cur \| prev) . . (+328)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Safety)
		18:20 (cur \| prev) . . (+1)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Indications)
		18:19 (cur \| prev) . . (-3)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Indications)
		18:19 (cur \| prev) . . (+446)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Indications)
		18:16 (cur \| prev) . . (+528)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Clinical trials)
		18:13 (cur \| prev) . . (+18)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Dosing and Administration)
		18:12 (cur \| prev) . . (-12)‎ . . Lalita.Gupta (Talk \| contribs) (→‎References)
		18:11 (cur \| prev) . . (+240)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Pharmacokinetics)
		18:09 (cur \| prev) . . (+1,911)‎ . . Lalita.Gupta (Talk \| contribs) (→‎Mechanism of Action)
		18:02 (cur \| prev) . . (+3,512)‎ . . Lalita.Gupta (Talk \| contribs) (Tag: VisualEditor: Switched)
	N	17:33 (cur \| prev) . . (+11,885)‎ . . Lalita.Gupta (Talk \| contribs) (Created page with "{{Article \|Authors=Lalita Gupta,Mark Prendes,Raymond Douglas \|Category=Oculoplastics/Orbit \|Date reviewed=February 21, 2021 \|Meta description=Teprotumumab is a fully human mon...")